Evidence map›Paper›PMID 24114239›Full record

ReviewReviews in endocrine & metabolic disorders2014

A proteolytic pathway that controls glucose uptake in fat and muscle.

Jonathan P Belman, Estifanos N Habtemichael, Jonathan S Bogan

Abstract readReview
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Positive Effects of Physical Activity on Insulin Signaling.Current issues in molecular biology · 2024
    Review
  5. Article
  6. The PI3K/Akt Pathway in Meta-Inflammation.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jonathan P BelmanSection of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, 333 Cedar Street, Box 208020, New Haven, CT, 06520-8020, USA.
Estifanos N Habtemichael
Jonathan S Bogan
Yale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
DIABETES MELLITUS &DISORDERS OF METABOLISMT32DK007058 · NIDDK · YALE UNIVERSITY · PI SONIA CAPRIO, Kevan C Herold · 1986 to 2026
$9.6M
Vesicle Translocation and the Metabolic SyndromeR01DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2018
$2.0M
Insulin stimulated ubiquitin-like modificationR01DK075772 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2007 to 2011
$1.5M
Regulation of insulin sensitivity by TUG acetylationR21AG041383 · NIA · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2013
$446k
TUG-mediated GLUT4 glucose transporter trafficking and regulation by post-translaF30DK093198 · NIDDK · YALE UNIVERSITY · PI BELMAN, JONATHAN PHILIP · 2011 to 2012
$88k
NIA NIH HHS R21 AG041383NIA NIH HHS R21AG041383NIDDK NIH HHS F30 DK093198NIDDK NIH HHS F30DK093198NIDDK NIH HHS R01 DK075772NIDDK NIH HHS R01DK075772NIDDK NIH HHS R01 DK092661NIDDK NIH HHS R01DK092661NIDDK NIH HHS T32 DK007058NIDDK NIH HHS T32DK007058NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Insulin regulates glucose uptake by controlling the subcellular location of GLUT4 glucose transporters. GLUT4 is sequestered within fat and muscle cells during low-insulin states, and is translocated to the cell surface upon insulin stimulation. The TUG protein is a functional tether that sequesters GLUT4 at the Golgi matrix. To stimulate glucose uptake, insulin triggers TUG endoproteolytic cleavage. Cleavage accounts for a large proportion of the acute effect of insulin to mobilize GLUT4 to the cell surface. During ongoing insulin exposure, endocytosed GLUT4 recycles to the plasma membrane directly from endosomes, and bypasses a TUG-regulated trafficking step. Insulin acts through the TC10α GTPase and its effector protein, PIST, to stimulate TUG cleavage. This action is coordinated with insulin signals through AS160/Tbc1D4 and Tbc1D1 to modulate Rab GTPases, and with other signals to direct overall GLUT4 targeting. Data support the idea that the N-terminal TUG cleavage product, TUGUL, functions as a novel ubiquitin-like protein modifier to facilitate GLUT4 movement to the cell surface. The C-terminal TUG cleavage product is extracted from the Golgi matrix, which vacates an "anchoring" site to permit subsequent cycles of GLUT4 retention and release. Together, GLUT4 vesicle translocation and TUG cleavage may coordinate glucose uptake with physiologic effects of other proteins present in the GLUT4-containing vesicles, and with potential additional effects of the TUG C-terminal product. Understanding this TUG pathway for GLUT4 retention and release will shed light on the regulation of glucose uptake and the pathogenesis of type 2 diabetes.

Indexed as

ProteolysisAdipose TissueAnimalsGlucoseGlucose Transporter Type 4InsulinMuscle, SkeletalProtein TransportGlucoseGlucose Transporter Type 4Insulin

Identifiers

PMID24114239
PMCPMC3943767
OpenAlexW2005465280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.